Janus Henderson Group plc 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-13 12:42 pm Sale | 2026-06-30 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP Ltd. JHG | 172,229 0.300% | -4,024,180 (-95.90%) | Filing |
| 2026-05-15 12:38 pm Sale | 2026-03-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP Ltd. JHG | 4,196,409 6.900% | -1,154,044 (-21.57%) | Filing |
| 2026-02-17 4:34 pm Sale | 2025-12-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP Ltd. JHG | 5,350,453 8.900% | -683,496 (-11.33%) | Filing |
| 2025-11-07 12:10 pm Purchase | 2025-10-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP Ltd. JHG | 6,033,949 10.000% | 1,573,617 (+35.28%) | Filing |
| 2025-08-14 11:26 am Sale | 2025-06-30 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP Ltd. JHG | 4,460,332 7.500% | -138,205 (-3.01%) | Filing |
| 2025-05-14 12:25 pm Purchase | 2025-03-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP Ltd. JHG | 4,598,537 7.800% | 1,036,135 (+29.09%) | Filing |
| 2025-02-14 11:24 am Purchase | 2024-12-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP Ltd. JHG | 3,562,402 6.100% | 1,724,611 (+93.84%) | Filing |
| 2023-02-09 11:40 am Sale | 2022-12-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP Ltd. JHG | 1,837,791 4.400% | -563,102 (-23.45%) | Filing |
| 2022-02-11 6:30 pm Purchase | 2021-12-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP Ltd. JHG | 2,400,893 5.800% | 2,400,893 (New Position) | Filing |